Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action
Introduction: MDD represents a significant burden worldwide, and while a number of approved treatments exist, there are high rates of treatment resistance and refractoriness. Ketamine, an N-methyl-d-aspartate receptor (NMDAR) antagonist, is a novel, rapid-acting antidepressant, however the mechanism...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
American Association of Psychiatric Pharmacists,
2021-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|